Keratitis fungal

The corticosteroid ophthalmic preparations are contraindicated in patients with acute superficial heq es simplex keratitis, fungal disease of the eye, or viral diseases of the eye, and after removal of a superficial comeal foreign body. 

Acute epithelial herpes simplex keratitis (dendritic keratitis) fungal diseases of ocular structures vaccinia, varicella and most other viral diseases of the cornea and conjunctiva ocular tuberculosis hypersensitivity after uncomplicated removal of a superficial corneal foreign body mycobacterial eye infection acute, purulent, untreated eye infections that may be masked or enhanced by the presence of steroids. 

The antibiotic and sulfonamide ophthalmics are contraindicated in patients with a hypersensitivity to the drug or any component of the drug. These dru are also contraindicated in patients with epithelial herpes simplex keratitis, varicella, mycobacterial infection of the eye, and fungal diseases of the eye There are no significant precautions or interactions when the dru are administered as directed by the primary health care provider. 

The rate of progression of signs and symptoms varies depending on the infecting organism. A differential diagnosis for keratitis must include viral, fungal, and nematodal infections in addition to bacterial causes.19... 

Thirty thousand cases of microbial keratitis occur annually in the United States.18 Microbial keratitis encompasses bacterial, fungal, and Acanthamoeba keratitis.19 Only bacterial keratitis, the most common form, is discussed here. 

Hypersensitivity to any component of these products epithelial herpes simplex keratitis (dendritic keratitis) vaccinia varicella mycobacterial infections of the eye fungal diseases of the ocular structure use of steroid combinations after uncomplicated removal of a corneal foreign body. 

Fungal infections Fungal blepharitis, conjunctivitis, and keratitis caused by susceptible organisms. Natamycin is the initial drug of choice in Fusarium solani keratitis. 

Fungal keratitis Instill 1 drop into the conjunctival sac at 1 or 2 hour intervals. The... 

Diagnosis/Monitoring Determine initial and sustained therapy of fungal keratitis by the clinical diagnosis (laboratory diagnosis by smear and culture of corneal... 

Efficacy In other conditions The clinical efficacy in the treatment of stromal keratitis and uveitis caused by herpes simplex or ophthalmic infections caused by vaccinia virus and adenovirus, or in the prophylaxis of herpes simplex virus keratoconjunctivitis and epithelial keratitis has not been established by well-controlled clinical trials. Not effective against bacterial, fungal, or chlamydial infections of the cornea or trophic lesions. 

Contraindications Hypersensitivity to ciprofloxacin or other quinolones for ophthalmic administration vaccinia, varicella, epithelial herpes simplex, keratitis, mycobacterial infection, fungal disease of ocular structure, use after uncomplicated removal of a foreign body... 

Fungal keratitis, ophthalmic fungal infections Ophthalmic Instill 1 drop in conjunctival sac every 1 -2 hr. After 3-4 days, reduce to 1 drop 6-8 times daily. Usual course of therapy is 2-3 wk. 

Contraindications Acute superficial herpes simplex keratitis, systemic fungal infections, varicella... 

Local or topical administration of amphotericin has been used with success. Mycotic corneal ulcers and keratitis can be cured with topical drops as well as by direct subconjunctival injection. Fungal arthritis has been treated with adjunctive local injection directly into the joint. Candiduria responds to bladder irrigation with amphotericin B, and this route has been shown to produce no significant systemic toxicity. 

A 15-year-old boy felt a foreign body sensation in his right eye after he had been raking hay. His local physician prescribed a suspension of tobramycin 0.3% + dexamethasone 0.1% tds, but 6 days later referred him for evaluation of a suspected fungal keratitis. He had a corneal epithelial defect with an underlying dense... 

Srinivasan, M. (2004) Fungal keratitis. Current Opinion in Ophthalmology 15, 321-327. 

Intracameral injection of amphotericin B may have a role in management of severe fungal keratitis not responding to topical treatment. 

Natamycin (pimaricin) Natacyn- 5% ophthalmic suspension 5% natamycin is the treatment of choice for treating filamentous fungal keratitis. Natamycin is more effective than itraconazole for treating Fusarium keratitis but is not effective in treating deep stromal infections. 

A prospective nonrandomized study compared the efficacy of 1% itraconazole drops with 5% natamycin for monotherapy of fungal keratitis. In patients with Fusarium keratitis, 79% responded favorably to natamycin compared with 44% to itraconazole (p <.02). Both treatments were well tolerated with no obvious adverse effects reported (Kalavathy et al.). 

Topical itraconazole appears effective in treating superficial, less severe fungal ulcers. Itraconazole may be less effective than natamycin for treating Fusarium keratitis. 

There is conflicting evidence regarding the efficacy of topical 0.2% fluconazole for treating filamentous fungal keratitis. 

Subconjunctival fluconazole may be effective for the treatment of severe fungal keratitis. 

A retrospective chart review of patients treated with topical 0.2% fluconazole for fQamentous fungal keratitis showed 16 of 23 patients had resolution of the keratitis. Less severe cases responded better and adding oral ketoconazole to topical treatment did not improve the treatment outcome (Sonego-Krone et al.). 

A small prospective study reported that 13 of 14 patients with severe fungal keratitis (Aspergillus, Pusarium, and Candida ) had resolution with subconjunctival fluconazole after failing to respond to topical and systemic fluconazole and itraconazole therapy. No local or systemic toxic side effects were reported (Yihnaz and Maden). 

Micafungin Mycamine injectable 50 mg IV infusion 50 mg/vial Topical micafungin shows potential as a treatment for fungal keratitis. 

Itraconazole is a broad-spectrum synthetic triazole that has good oral bioavailability and is less toxic than amphotericin B and ketoconazole.The solution has better bioavailability than the capsule and provides higher plasma concentration levels. Compared with fluconazole and ketoconazole, itraconazole penetrates all ocular tissues poorly when orally administered. Itraconazole can be used as a 1% ophthalmic suspension but is not very effective in treating severe fungal keratitis. 

Acanthamoeba keratitis is known to be difficult to diagnosis and to treat. Most patients are initially treated fiar viral, fungal, of bacterial keratitis before the diagnosis of Acanthamoeba. Most Acanthamoeba infections are associated with contact lens wear (85% to 92%), but a smaller number are secondary to trauma. The incidence of Acanthamoeba keratitis may be greater than 1 per 30,000 contact lens wearers per year as indicated by cohort studies and questionnaires. The frequency oi Acanthamoeba keratitis in contact lens wearer may be 1 per 10,000/year or higher. 

Kalavathy CM, Parmar P, Kahamurthy J, et al. Comparison of topical itraconazole 1% with topical natamycin 5% for the treatment of filamentous fungal keratitis. Cornea 2005 24(4) 449-452. 

Marangon FB, Miller D, Giaconi JA, et al. In vitro investigation of voriconazole susceptibility for keratitis and fungal pathogens. AmJ Ophthalmol 2004 137(5) 820-825. 

Sonego-Krone S, Sanchez-DiMartino D, Ayala-Lugo R, et al. Clinical results of topical fluconazole for the treatment of filamentous fungal keratitis. Graefes Arch Clin Exp Ophthalmol 2005. 

Wu Z, Yiug H,Yiu S, et al. Fungal keratitis caused by Scedosporium aptospermun. Report of two cases and review of treatment. Cornea 2002 21(5) 519-523. 

Yilmaz S, Maden A. Severe fungal keratitis treated with subconjunctival fluconazole. AmJ Ophthalmol 2005 140(3) 454-458. 

Patients receiving topical ocular steroids must be examined periodically for corneal, lens, and lOP changes. Slit-lamp examination for pimctate, herpetic, or fungal keratitis... 

During the examination, and when considering the history of the traumatic episode, it is important to rule out corneal laceration or penetration, retained foreign bodies, or other ocular traumatic sequelae. Clean corneal abrasions should not exhibit opaque infiltration suggestive of bacterial or fungal keratitis. 

Because most corneal abrasions involve loss of only the superficial epithelial cells, the lesions generally heal in 24 to 72 hours without scar formation. As the cornea is monitored during follow-up care, it is important to determine that the signs and symptoms are consistent with the healing of a clean abrasion and that bacterial or fungal keratitis does not develop, particularly in abrasions caused by vegetative matter. Once the acute care aspects associated with the abrasion are resolved, it is helpful to discuss with the patient the appropriateness of protective eyewear, particularly if the patient is monocular. Protective eyewear may be needed in occupational, domestic, or recreational settings. 

A follow-up examination is perfttrmed 24 hours later. During follow-up examinations it is important to monitor for signs of secondary bacterial keratitis, secondary fungal keratitis, or an intraocular foreign body that may have... 

Unlike dendritic keratitis, indolent ulcers are typically very difficult to treat. Instillation of a prophylactic antibiotic, such as polymyxin B-bacitracin ointment two to four times a day, and a cycloplegic agent, such as 5% homatropine two to three times a day, is indicated. Therapeutic soft contact lens use with appropriate antibiotic therapy can also be considered as alternatives. These patients must be monitored carefully to ensure that no secondary infection develops. If the ulcer deepens, a new infiltrate forms, or if there is an increase in the anterior chamber reaction while the patient is being treated, cultures should be performed to rule out bacterial or fungal infection. Cyanoacrylate glue, conjunctival flap surgery, or tarsorrhaphy may be required if healing does not occur. 

---